Evidence map›Paper›PMID 38228781›Full record

ArticleScientific reports2024

Raman spectra simulation of antiplatelet drug-platelet interaction using DFT.

Anna Kundalevich, Anastasia Kapitunova, Kirill Berezin, Andrey Zyubin, Ekaterina Moiseeva, Vladimir Rafalskiy, Ilia Samusev

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Anna KundalevichImmanuel Kant Baltic Federal University, REC "Fundamental and Applied Photonics", Nanophotonics, Kaliningrad, 236016, Russia. kundalevich3@mail.ru.
Anastasia KapitunovaImmanuel Kant Baltic Federal University, REC "Fundamental and Applied Photonics", Nanophotonics, Kaliningrad, 236016, Russia.
Kirill BerezinInstitute of Physics, Saratov State University, Saratov, 410012, Russia.
Andrey ZyubinImmanuel Kant Baltic Federal University, REC "Fundamental and Applied Photonics", Nanophotonics, Kaliningrad, 236016, Russia.
Ekaterina MoiseevaImmanuel Kant Baltic Federal University, Kaliningrad, 236016, Russia.
Vladimir RafalskiyImmanuel Kant Baltic Federal University, Kaliningrad, 236016, Russia.
Ilia SamusevImmanuel Kant Baltic Federal University, REC "Fundamental and Applied Photonics", Nanophotonics, Kaliningrad, 236016, Russia.
Immanuel Kant Baltic Federal University · RUInstitute of Physics · RU

Funding

Ministry of Science and Higher Education of the Russian Federation 075-02-2023-934
6 · The paper itself

Abstract

The paper reflects the results of molecular docking and mathematical DFT simulation for antiplatelet drugs and the target platelet receptor/ferment interaction in the limited area. The results of Raman spectra simulation are implemented and obtained from the interaction of the clopidogrel metabolite of the P2Y12 receptor. The interaction of aspirin with the COX-1 enzyme was also investigated. As a result, theoretical Raman spectra of the drug-receptor area were obtained. The theoretical data were compared with the experimental SERS results. The characteristic bands corresponding to metabolite/ferment and antiplatelet drug vibrations were clarified. The prospects of obtaining results for pathologies based on platelet conformations during cardiovascular diseases have been demonstrated.

Indexed as

AspirinPlatelet Aggregation InhibitorsBlood PlateletsClopidogrelMolecular Docking SimulationAspirinClopidogrelPlatelet Aggregation Inhibitors

Identifiers

PMID38228781
PMCPMC10792092
OpenAlexW4390902120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.